mitoxantrone has been researched along with Retinal Degeneration in 1 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
Retinal Degeneration: A retrogressive pathological change in the retina, focal or generalized, caused by genetic defects, inflammation, trauma, vascular disease, or aging. Degeneration affecting predominantly the macula lutea of the retina is MACULAR DEGENERATION. (Newell, Ophthalmology: Principles and Concepts, 7th ed, p304)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ramirez, CJ | 1 |
| Minch, JD | 1 |
| Gay, JM | 1 |
| Lahmers, SM | 1 |
| Guerra, DJ | 1 |
| Haldorson, GJ | 1 |
| Schneider, T | 1 |
| Mealey, KL | 1 |
1 other study available for mitoxantrone and Retinal Degeneration
| Article | Year |
|---|---|
Molecular genetic basis for fluoroquinolone-induced retinal degeneration in cats.
Topics: Amino Acid Sequence; Animals; ATP-Binding Cassette Transporters; Base Sequence; Boron Compounds; Cat | 2011 |